BELGOPHARMA

Anderlecht ·KBO/BCE: BE 0762.935.682

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	68.2%	31.0%	better than 85% of 545 sector peers
Net result	€1.24M	€47k	better than 87% of 545 sector peers
Equity	€2.26M	€476k	better than 72% of 546 sector peers
Gross operating margin	€1.77M	€125k	better than 95% of 337 sector peers
Staff costs	€17k	€496k	higher than 7% of 401 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€3.32M
Fixed assets	21/28	€14k
Tangible fixed assets	22/27	€4k
Financial fixed assets	28	€10k
Current assets	29/58	€3.30M
Stocks & contracts in progress	3	€54k
Amounts receivable within one year	40/41	€946k
Cash & bank	54/58	€1.92M
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€3.32M
Equity	10/15	€2.26M
Contributions / capital	10/11	€6k
Reserves	13	€1.30M
Accumulated profits (losses)	14	€956k
Amounts payable	17/49	€1.05M
Amounts payable within one year	42/48	€1.05M
Trade debts payable within one year	44	€516k
Income statement
Gross operating margin	9900	€1.77M
Operating result	9901	€1.75M
Financial charges	65	€355
Result before taxes	9903	€1.75M
Income taxes	67/77	€512k
Net result for the period	9904	€1.24M
Result to be appropriated	9905	€1.24M

Summary